Listed

NextCure, Inc.

NXTCNasdaqCIK 1661059HealthcareFiscal year ends Dec 31

All transactions: 3

Non-derivative transactions reported on Forms 4, newest first. Purchases and sales (codes P and S) are open-market trades; the other codes are grants, exercises, withholding and gifts. The reported price is as stated on the form, not a market price.

What these mean: insiders, Form 4, transaction codes, Rule 10b5-1 plans.

By month, by reported value, last 24 monthsPurchases $53.7kSales $0
NextCure, Inc., insider transactions
DateInsiderTransactionSharesReported priceValueFiling
2026-10-27ADAR1 Capital Management, LLC10% owner Purchase3,553$5.0953$18.1kForm 4
2026-10-26ADAR1 Capital Management, LLC10% owner Purchase1,672$5.0344$8.4kForm 4
2026-10-23ADAR1 Capital Management, LLC10% owner Purchase5,626$4.8294$27.2kForm 4

Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 30, 2026, 08:01 ET. Listed shows no prices and gives no investment advice.